Ataxin-2 polyQ expansions in FTLD-ALS spectrum disorders in Flanders-Belgian cohorts
暂无分享,去创建一个
P. Deyn | C. Broeckhoven | S. Engelborghs | R. Vandenberghe | M. Cruts | M. Broeck | P. Cras | P. Santens | P. Jonghe | K. Peeters | J. Zee | M. Mattheijssens | Dirk Nuytten | T. Langenhove | T. V. Langenhove | Maria Mattheijssens
[1] B. Miller,et al. Ataxin-2 repeat-length variation and neurodegeneration. , 2011, Human molecular genetics.
[2] P. Andersen,et al. Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients. , 2011, Human molecular genetics.
[3] K. Sleegers,et al. TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort , 2011, Brain : a journal of neurology.
[4] I. Mackenzie,et al. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia , 2010, The Lancet Neurology.
[5] John Q. Trojanowski,et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS , 2010, Nature.
[6] K. Sleegers,et al. Genetic contribution of FUS to frontotemporal lobar degeneration , 2010, Neurology.
[7] Ewout J N Groen,et al. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis , 2009, Nature Genetics.
[8] S. Engelborghs,et al. Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His , 2009, Neurology.
[9] C. Gellera,et al. Rare association of motor neuron disease and spinocerebellar ataxia type 2 (SCA2): a new case and review of the literature , 2009, Journal of Neurology.
[10] J. L. Mesa,et al. Molecular epidemiology of spinocerebellar ataxias in Cuba: Insights into SCA2 founder effect in Holguin , 2009, Neuroscience Letters.
[11] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[12] C. Duijn,et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.
[13] H. Horvitz,et al. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia , 2006, Neurology.
[14] O. Combarros,et al. Spinocerebellar ataxia type 2 with levodopa‐responsive parkinsonism culminating in motor neuron disease , 2004, Movement disorders : official journal of the Movement Disorder Society.
[15] Catherine Lomen-Hoerth,et al. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia , 2002, Neurology.
[16] M. Farrer,et al. Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese , 2000, Neurology.
[17] T. Bird,et al. Late-onset SCA2: 33 CAG repeats are sufficient to cause disease , 2000, Neurology.
[18] Yves Agid,et al. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats , 1996, Nature Genetics.
[19] T. Bird,et al. Late-onset SCA2 , 2000 .